News Search

Researchers at Columbia used genomic profiling and machine learning to uncover genetic programs driving brain metastases in non-small cell lung cancer.

Dr. Sadelain will serve as director of Columbia University Irving Medical Center’s Cancer Cell Therapy Initiative in the Herbert Irving Comprehensive Cancer Center.

In this Q&A, Edmond Chan discusses his current work on synthetic lethality, including an ongoing clinical trial and major new basic research findings.

After a career transition from cancer biology research to community outreach, Chrystelle Vilfranc, PhD, is bridging the gap between scientific discovery and public engagement at the HICCC.